抗体介导的syndecan-4二聚化抑制减少IL-1受体转运与信号传导
该研究探讨syndecan-4(sdc4)二聚化如何影响成纤维细胞对IL-1的应答。研究发现IL-1直接结合sdc4并诱导其二聚化,进而调控IL1R1的囊泡转运和细胞表面表达;阻断sdc4二聚化的抗体在体外和动物模型中均降低关节炎成纤维细胞IL1R1表达,提示其可能辅助抗IL-1策略。
要点
- IL-1直接结合sdc4并以不依赖IL-1R的方式诱导sdc4二聚化。
- sdc4二聚化调控caveolin囊泡介导的IL1R1转运,决定细胞对IL-1的敏感性。
- 抗sdc4二聚化抗体在体外和动物模型中降低关节炎成纤维细胞IL1R1表达。
核心结论
- 特异性抑制sdc4二聚化的抗体可能支持炎症性关节炎等疾病的抗IL-1策略。
研究设计与样本
- 研究对类风湿关节炎组织切片进行sdc4免疫染色,并在成纤维细胞和人类TNF-α转基因小鼠中开展实验。
- 采用免疫沉淀研究IL-1与sdc4结合,用流式细胞术分析野生型、sdc4敲除和IL1R1敲除成纤维细胞的IL1R1染色。
- 使用阻断性sdc4抗体研究sdc4二聚化、IL1R1表达及小鼠足爪组织学破坏。
主要发现
- 在成纤维细胞中,sdc4缺失或抗体介导的sdc4二聚化抑制降低IL-1R细胞表面表达并调节对IL-1的敏感性。
- IL-1直接结合sdc4并以不依赖IL-1R的方式导致其二聚化。
- IL-1诱导的sdc4二聚化调控caveolin囊泡介导的IL1R1转运,从而决定对IL-1的应答性。
- 抗sdc4二聚化结构域抗体在体外和人类RA动物模型中均强烈降低关节炎成纤维细胞IL1R1表达。
临床怎么用
- 靶向sdc4二聚化可能作为辅助手段增强抗IL-1治疗在炎症性关节炎中的效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Syndecan-4 (sdc4) is a cell-anchored proteoglycan that consists of a transmembrane core protein and glucosaminoglycan (GAG) side chains. Binding of soluble factors to the GAG chains of sdc4 may result in the dimerisation of sdc4 and the initiation of downstream signalling cascades. However, the question of how sdc4 dimerisation and signalling affects the response of cells to inflammatory stimuli is unknown. METHODS: Sdc4 immunostaining was performed on rheumatoid arthritis (RA) tissue sections. Interleukin (IL)-1 induced extracellular signal-regulated kinases (ERK) phosphorylation and matrix metalloproteinase-3 production was investigated. Il-1 binding to sdc4 was investigated using immunoprecipitation. IL-1 receptor (IL1R1) staining on wild-type, sdc4 and IL1R1 knockout fibroblasts was performed in fluorescence-activated cell sorting analyses. A blocking sdc4 antibody was used to investigate sdc4 dimerisation, IL1R1 expression and the histological paw destruction in the human tumour necrosis factor-alpha transgenic mouse. RESULTS: We show that in fibroblasts, the loss of sdc4 or the antibody-mediated inhibition of sdc4 dimerisation reduces the cell surface expression of the IL-1R and regulates the sensitivity of fibroblasts to IL-1. We demonstrate that IL-1 directly binds to sdc4 and in an IL-1R-independent manner leads to its dimerisation. IL-1-induced dimerisation of sdc4 regulates caveolin vesicle-mediated trafficking of the IL1R1, which in turn determines the responsiveness to IL-1. Administration of antibodies (Ab) against the dimerisation domain of sdc4, thus, strongly reduces the expression IL1R1 on arthritic fibroblasts both in vitro and an animal model of human RA. CONCLUSION: Collectively, our data suggest that Ab that specifically inhibit sdc4 dimerisation may support anti-IL-1 strategies in diseases such as inflammatory arthritis.
引用
- Godmann L, Bollmann M, Korb-Pap A, et al. Antibody-mediated inhibition of syndecan-4 dimerisation reduces interleukin (IL)-1 receptor trafficking and signalling. Ann Rheum Dis. 2020. PMID: 32094158. doi:10.1136/annrheumdis-2019-216847
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。